Regencell Bioscience Holdings Ltd (RGC)
6.30
+0.20
(+3.28%)
USD |
NASDAQ |
Nov 15, 16:00
6.30
0.00 (0.00%)
After-Hours: 17:00
Regencell Bioscience Holdings Total Liabilities (Quarterly): 0.2195M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.2195M |
| December 31, 2023 | 0.3126M |
| December 31, 2023 | 0.3126M |
| June 30, 2023 | 0.6323M |
| December 31, 2022 | 0.8738M |
| December 31, 2022 | 0.8738M |
| June 30, 2022 | 0.938M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.364M |
| December 31, 2021 | 1.364M |
| June 30, 2021 | 4.338M |
| December 31, 2020 | 3.585M |
| December 31, 2020 | 3.585M |
| June 30, 2020 | 3.165M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.2195M
Minimum
Jun 2024
4.338M
Maximum
Jun 2021
1.659M
Average
0.938M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Sino Biopharmaceutical Ltd | 3.382B |
| HUTCHMED (China) Ltd | 508.85M |
| Pharmaron Beijing Co Ltd | 1.420B |
| Prenetics Global Ltd | 42.30M |
| Uni-Bio Science Group Ltd | 22.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.438M |
| Shareholders Equity (Quarterly) | 8.219M |